Squarex
Preventing oral herpes with a topical application to the arm
Overview
Raised: $235,067
Rolling Commitments ($USD)
03/30/2022
$1,391
173
2012
Healthcare & Pharmaceuticals
Biotech
B2B/B2C
Medium
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-411,793 |
$-742,002 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$4,509 |
$14,037 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$4,918 |
$15,745 |
Short-Term Debt |
$30,510 |
$19,945 |
Long-Term Debt |
$469,979 |
$99,523 |
Total Liabilities |
$500,489 |
$119,468 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual